Views & Analysis England’s ‘world-first’ cancer database – can it deliver on ... The world's first national database of cancer treatment outcomes has been launched in England.
Views & Analysis What doctors say about changes to the Cancer Drugs Fund Assessing HCPs’ social media comments about the new approach to cancer drug funding.
News Xalkori gains NICE approval after price cut NICE approval secured against background of renewed controversy
News NICE says no to liver cancer drug Nexavar Liver cancer treatment latest earmarked for removal from CDF
News Adcetris falls victim to NICE’s Cancer Drugs Fund clear-out More CDF legacy products likely to face same fate
Views & Analysis Saving the jewel in the crown of ‘UKplc’: Brexit's impact on... Pharma must embrace the opportunity to shape the UK’s political agenda in its favour.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
